EXPLAINER: Why Elizabeth Holmes’ trial hinges on intent

Published December 21, 2021 12:01 AM

By MICHAEL LIEDTKE
AP Technology Writer

SAN JOSE, Calif. (AP) — The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients? Federal prosecutors charged Holmes, 37, with 11 felony counts of fraud and conspiracy in 2018 after Theranos collapsed under the weight of her bogus boasts about its technological prowess.. While telling her own story on the stand, Holmes acknowledged making some bad decisions and other mistakes while insisting she never stopped believing Theranos was on the verge of transforming health care..

Article Topic Follows: AP California

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

News Channel 3 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.